Maruyama F, Yang P, Stass S A, Cork A, Freireich E J, Lee M S, Chang K S
Hematopathology Program, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Cancer Res. 1993 Oct 1;53(19):4449-51.
The fusion transcript AML1/ETO was detected in the bone marrow of two t(8;21)-negative acute myelogenous leukemia (AML) patients by means of reverse transcription-polymerase chain reaction. This fusion transcript is identical to the one transcribed from the t(8;21) translocation base, as deduced from (a) the size and restriction pattern of the amplified DNA fragment and (b) the DNA sequence analysis of the fusion junction. We also showed that the ETO gene is highly expressed in these patients, much as it is in the t(8;21)-positive AML. Southern blot analysis showed rearrangement of the AML1 gene in one of the patients. Together, our results demonstrate that there is a masked t(8;21) translocation in AML that is not detectable by cytogenetic analysis but is able to transcribe an AML1/ETO fusion transcript similar to that transcribed in t(8;21)-positive AML-M2 patients.
通过逆转录聚合酶链反应在两名t(8;21)阴性急性髓性白血病(AML)患者的骨髓中检测到融合转录本AML1/ETO。从(a)扩增DNA片段的大小和限制性酶切图谱以及(b)融合接头的DNA序列分析推断,该融合转录本与从t(8;21)易位碱基转录的转录本相同。我们还表明,ETO基因在这些患者中高度表达,与t(8;21)阳性AML患者中的情况非常相似。Southern印迹分析显示其中一名患者的AML1基因发生了重排。总之,我们的结果表明,AML中存在一种隐蔽的t(8;21)易位,细胞遗传学分析无法检测到,但能够转录出与t(8;21)阳性AML-M2患者中相似的AML1/ETO融合转录本。